本網站銷售的所有產品僅用于工業應用或者科學研究等非醫療目的,不可用于人類或動物的臨床診斷或者治療,非藥用,非食用。
阿維魯單抗
英文名:Avelumab
Cas號:1537032-82-8
Cas號:1537032-82-8
檢測信息查詢
| 貨號 | 規格 | 貨期 | 庫存 | 價格 | 促銷價 | 訂購 |
| 1308132488-1mg | 0 | ¥17000 | ||||
| 1308132488-5mg | 0 | ¥50000 |
| 別 名 | |
| Cas號 | 1537032-82-8 |
| M D L | |
| 分子式 | |
| 分子量 | |
| 產品參數 | Description
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity. IC50 & Target PD-1/PD-L1[1] References [1]. Fujii R, et al. Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget. 2016 Jun 7;7(23):33498-511. [2]. Grenga I, et al. A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology. 2016 May 20;5(5):e83. [3]. Vandeveer AJ, et al. Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res. 2016 May;4(5):452-62. |
| 性狀 | Avelumab 是一個人 IgG1 抗 PD-L1 單克隆抗體,具有潛在的抗體依賴性細胞介導的細胞毒性作用。 |
| 貯存 | Storage Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
小程序掃碼下單
滬公網安備 31012002003054號